Most Recent
Neurim’s patent for mini melatonin put to sleep
Israeli drug company Neurim Pharmaceuticals has lost a bid to patent a mini version of its melatonin tablet Circadin for children, after a successful challenge by Australian drug maker Generic Partners.
22 firms launch group to advise businesses on human rights
A coalition of global law firms have joined together to launch an association to advise businesses on adopting better human rights practices.
Allianz loses fight with Probuild over $1B West Side Place development bonds
Insurer Allianz has lost its bid to claw back millions in performance bonds provided to collapsed building company Probuild in relation to works at a $1 billion development in the Melbourne CBD.
Blue Star Helium’s former CEO stuck with ban after High Court rejects appeal
The High Court has turned down the appeal of the former Blue Star Helium CEO who was hit with a $40,000 penalty and four-year ban after the company failed to disclose to shareholders the identity of the buyer behind a botched sale of Texas oil assets.
Court slaps Smile Direct Club with $3.5M penalty for misleading insurance claims
A judge has ordered Smile Direct Club and its Australian unit to pay a $3.5 million penalty and reimburse customers for misleading them into believing they would be reimbursed by their insurers for the dental care company's costly teeth straighteners.
Judge warns Domino’s about ‘trial by ambush’ as underpayments class action hearing kicks off
A judge has slammed Domino’s for its “entirely unsatisfactory” opening submissions in an underpayments class action, warning the pizza giant not to hide arguments and evidence up its sleeve.
ACCC accuses Fitbit of misleading consumers about refund rights
The Australian Competition and Consumer Commission has dragged Google-owned Fitbit to court for allegedly telling consumers they had to mail in broken devices within 45 days in order to obtain a refund.
Full Court upholds validity of Pfizer’s Dynastat patent
A judge has thrown out competing appeals of a decision finding Pfizer's patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.
Ex-Blue Star Helium CEO appeals banning order to High Court
The former CEO of Blue Star Helium has asked the High Court to throw out a $40,000 penalty and four-year ban imposed on him after the company failed to disclose to shareholders the identity of the buyer behind a botched sale of Texas oil assets.
Oil company ‘holding a gun to court’s head’ to delay $328M East Timor dispute, judge says
Lighthouse Corporation was holding "a gun to the head” of the court in seeking to adjourn a $480,000 bid for security in a dispute with East Timor over $328 million in alleged losses from a failed fuel supply agreement, a judge has said.